Parkman Healthcare Partners LLC - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 254 filers reported holding TG THERAPEUTICS INC in Q2 2024. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.

Quarter-by-quarter ownership
Parkman Healthcare Partners LLC ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$3,207,893
+36.0%
180,320
+16.3%
0.43%
+48.8%
Q1 2024$2,358,143
-32.8%
155,039
-24.5%
0.29%
-41.5%
Q4 2023$3,506,814
+100.4%
205,317
-1.9%
0.49%
+53.9%
Q3 2023$1,749,907
-68.1%
209,319
-5.1%
0.32%
-66.2%
Q2 2023$5,480,549
+32.2%
220,634
-20.0%
0.95%
+5.3%
Q1 2023$4,145,641275,6410.90%
Other shareholders
TG THERAPEUTICS INC shareholders Q2 2024
NameSharesValueWeighting ↓
Darwin Global Management, Ltd. 10,451,241$157,186,66542.99%
M28 Capital Management LP 339,500$5,106,0805.77%
Ghost Tree Capital, LLC 1,100,000$16,544,0004.89%
Soleus Capital Management, L.P. 750,300$11,284,5121.17%
Parkman Healthcare Partners LLC 275,641$4,145,6410.90%
683 Capital Management, LLC 775,000$11,656,0000.87%
Leucadia National 5,100,110$76,705,6540.62%
Pier Capital, LLC 233,472$3,511,4190.53%
Harvest Investment Services, LLC 40,729$612,5640.47%
Artal Group S.A. 511,389$7,6910.46%
View complete list of TG THERAPEUTICS INC shareholders